ENZN : Summary for ENZON PHARMACEUTIC COM USD0.01 - Yahoo Finance

We are experiencing some temporary issues. The market data on this page are currently delayed. Please bear with us as we address this and restore your personalized lists.

U.S. Markets open in 8 hrs 34 mins

Enzon Pharmaceuticals, Inc. (ENZN)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.37 0.00 (0.00%)
At close: 3:57PM EST
People also watch
QLTI ALKS PDLI IMMU MYGN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close 0.37
Open 0.00
Bid 0.38 x 3000
Ask 1.41 x 200
Day's Range 0.00 - 0.00
52 Week Range
Volume 0
Avg. Volume 222,479
Market Cap 16.36M
Beta 1.11
PE Ratio (TTM) 1.03
EPS (TTM) 0.36
Earnings Date N/A
Dividend & Yield 0.00 (0.00%)
Ex-Dividend Date N/A
1y Target Est 14.00
Trade prices are not sourced from all markets
  • Carl Icahn Takes 15% Stake in Enzon Pharmaceuticals
    GuruFocus.com 2 months ago

    Carl Icahn Takes 15% Stake in Enzon Pharmaceuticals

    Activist investor continues his interest in penny stock

  • Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016
    Capital Cube 2 months ago

    Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016

    Categories: Yahoo Finance Get free summary analysis Enzon Pharmaceuticals, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Enzon Pharmaceuticals, Inc. – Nektar Therapeutics, Amgen Inc., Merck & Co., Inc., XOMA Corporation, Bristol-Myers Squibb Company, Pfizer Inc., SciClone Pharmaceuticals, Inc., Vertex Pharmaceuticals Incorporated and Gilead Sciences, ... Read more (Read more...)

  • Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016
    Capital Cube 5 months ago

    Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016

    Categories: Yahoo Finance Click here to see latest analysis Enzon Pharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Enzon Pharmaceuticals, Inc. – Nektar Therapeutics, Enanta Pharmaceuticals, Inc., Amgen Inc., Merck & Co., Inc., XOMA Corporation, Bristol-Myers Squibb Company, Pfizer Inc., Vertex Pharmaceuticals Incorporated and ... Read more (Read more...)

  • Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016
    Capital Cube 8 months ago

    Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016

    Click here to see latest analysisEnzon Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2016.We analyze the earnings along side the following peers of Enzon Pharmaceuticals, Inc. – Nektar Therapeutics, Enanta Pharmaceuticals, Inc., Amgen Inc., Merck & Co., Inc., XOMA Corporation, Bristol-Myers Squibb Company, Pfizer Inc., SciClone Pharmaceuticals, Inc., Vertex Pharmaceuticals Incorporated […] (Read more...) The post Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016 appeared first on CapitalCube.

  • Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: 2015 By the Numbers
    Capital Cube 10 months ago

    Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: 2015 By the Numbers

    Click here to see latest analysisEnzon Pharmaceuticals, Inc. reports financial results for the year ended December 31, 2015.We analyze the earnings along side the following peers of Enzon Pharmaceuticals, Inc. – Nektar Therapeutics, Enanta Pharmaceuticals, Inc., Amgen Inc., Merck & Co., Inc., XOMA Corporation, Bristol-Myers Squibb Company, Pfizer Inc., SciClone Pharmaceuticals, Inc., Vertex Pharmaceuticals Incorporated […] (Read more...) The post Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: 2015 By the Numbers appeared first on CapitalCube.

  • Enzon Pharmaceuticals, Inc. Earnings Analysis: Q3, 2015 By the Numbers
    Capital Cube last year

    Enzon Pharmaceuticals, Inc. Earnings Analysis: Q3, 2015 By the Numbers

    Click here to see latest analysisEnzon Pharmaceuticals, Inc. reports financial results for the quarter ended September 30, 2015.Enzon Pharmaceuticals, Inc. has an earnings momentum score of 21.99 and has a relative valuation rating of UNDERVALUED. HighlightsSummary numbers: Revenues of USD 3.84 million, Net Earnings of USD -1.81 million, and Earnings per Share (EPS) of USD […] (Read more...) The post Enzon Pharmaceuticals, Inc. Earnings Analysis: Q3, 2015 By the Numbers appeared first on CapitalCube.

  • Enzon Pharmaceuticals Inc (ENZN)’s Shares Rally After Special Cash Dividend Announcement
    Insider Monkey 2 years ago

    Enzon Pharmaceuticals Inc (ENZN)’s Shares Rally After Special Cash Dividend Announcement

    The shares of Enzon Pharmaceuticals Inc (NASDAQ:ENZN) have rallied in excess of 16% in trading today after the company announced a special cash dividend for its investors. The biotechnology company will pay the special dividend on August 12, 2015 to its shareholders of record on July 21, 2015. One of the most impressive facts about

  • Voltari Corp (VLTC): Carl Icahn Stirring Yet Another Pot
    Insider Monkey 2 years ago

    Voltari Corp (VLTC): Carl Icahn Stirring Yet Another Pot

    In a recent filing with SEC, Carl Icahn of Icahn Capital Lp disclosed an activist stake of 4.74 million shares in Voltari Corp (NASDAQ:VLTC). Nearly 4.06 million shares were purchased at $1.36 per share upon the exercise of basic subscription and oversubscription rights during Voltari’s Rights Offering that expired on March 20. The holding which

  • TheStreet.com 2 years ago

    DELiA*s Rebounds As Reports Suggest Delisting May Be Imminent

    Billionaire stock picks dELiA*s, Inc. (NASDAQ:DLIA), AngloGold Ashanti Limited (ADR) (NYSE:AU) and Enzon Pharmaceuticals Inc (NASDAQ:ENZN) made big gains early in the day this Monday. Moving in the o......

  • TheStreet.com 2 years ago

    George Soros Picks KIOR, RSH, BIOL Soar On Monday

    KiOR Inc (NASDAQ:KIOR), RadioShack Corporation (NYSE:RSH) and BIOLASE Inc (NASDAQ:BIOL) are today's top-gaining billionaire stock picks. On the losing end are NII Holdings Inc (NASDAQ:NIHD), dELiA...